People who have their evening meal before 9 pm or wait at least two hours before going to sleep have a 20% lower risk of breast and prostate cancer
Early Supper Associated With Breast and Prostate Cancer Risk Read More »
The IDIBELL colorectal cancer research team, led by Dr. Vïctor Moreno, has contributed to a large-scale study that led to the description of 11 new genetic variants associated with this type of cancer. This study, published in in the Journal of the National Cancer Institute, provides insight into the architecture of common genetic variation contributing
Novel Common Genetic Susceptibility Loci for Colorectal Cancer Read More »
The best-known way our cells and tissues store biological information is their genetic code, derived from the DNA sequence (Deoxyribonucleic Acid). During the last two decades, the epigenetic code has been identified as capable of controlling our DNA through a series of chemical tags. Today, an article published in Cell by Manel Esteller, coordinator of
The Third Warehouse of Biological Information: The RNA Code Read More »
Hereditary Colorectal Cancer. Genetic Basis and Clinical Implications Researchers of the Hereditary Cancer Program of the Catalan Institute of Oncology, IDIBELL (Oncobell), Dr. Laura Valle and Dr. Gabriel Capellá, together with Dr. Stephen B. Gruber of the Norris Comprehensive Cancer Center (University of Southern California), have published a book on hereditary colorectal cancer entitled “Hereditary
New books by IDIBELL authors: hereditary colorectal cancer & stem cell genetics Read More »
Under the coordination of the University of Turin in Italy, members of the EurOPDX Consortium and additional key European academic and SME partners recently secured 5 million € from the European Union’s Horizon 2020 research and innovation programme to build an infrastructure for access to patient-derived cancer xenograft (PDX) models and related data, for academic
